F. NO. 8 (2)/2006/DP/NPPA-Div.II
GOVERNMENT OF INDIA
MINISTRY OF CHEMICALS AND FERTILIZERS
NATIONAL PHARMACEUTICAL PRICING AUTHORITY
NEW DELHI, DATED THE 01/05/2006
ORDER
In exercise of the powers, conferred by sub-paragraph (1)/(2)/(4) of paragraph 8 of the Drugs (Price Control) Order, 1995, read with No. S.O. 637(E) dated the 4th September, 1997 issued by the Government of India in the Ministry of Chemicals and Fertilizers, the National Pharmaceutical Pricing Authority hereby fixes/revises the prices as specified in column (7) of the Table hereto annexed as the retail price/revised retail price, exclusive of local tax if any, in relation to each of the formulations specified in the corresponding entry in column (2) of the said Table with pack size specified in the corresponding entries in column (3) thereof;
TABLE
| Sl. No. | Name of the Formulation | Pack Size | Existing Retail Price (Rs.) | Retail Price without Excise Duty | Excise Duty (Rs.) | Revised Retail Price with Excise Duty (Rs.) |
|---|---|---|---|---|---|---|
| 1 | Monocomponent Insulin Huminsulin 30/70 100 IU / ml (30% Neutral Insulin Solution & 70% Isophane Suspension Human) Batch No. – FF5T34E/ Qty.100000 Cartridges |
3ml Cartridge | 208.94 | 208.94 | 0.00 | 208.94 |
| 2 | Monocomponent Insulin Huminsulin 50 / 50 100 IU / ml (50% Neutral Insulin Solution & 50% Isophane Suspension Human) Batch No. – FF5AJ7A / Qty.10822 vial Batch No. – FF5V45B / Qty. 6000 vial |
10ml Vial | 403.87 | 406.48 | 0.00 | 406.48 |
| 3 | Monocomponent Insulin Humalog 100 IU / ml (Insulin lispro) Each ml contains: 100 IU (3.5mg) Insulin Lispro (r-DNA Origin) as active ingredient. Batch No. – FF6C55E / Qty.9000 Cartridges Batch No. – FF5Z74D / Qty.11500 Cartridges |
3ml Cartridge | 417.15 | 419.13 | 0.00 | 419.13 |
| 4 | Monocomponent Insulin Huminsulin Regular 100 IU/ml (Insulin Human Injection) Batch No. – HIR034A / Qty. 7696 vial |
10ml Vial | 402.07 | 408.10 | 0.00 | 408.10 |
| 5 | Monocomponent Insulin Huminsulin 30/70 100 IU / ml (30% Neutral Insulin Solution & 70% Isophane Suspension Human) Batch No. – HIM200 / Qty.20280 vial |
10ml Vial | 405.97 | 408.10 | 0.00 | 408.10 |
| 6 | Monocomponent Insulin Huminsulin NPH 100 IU/ml (Isophane Insulin Human Suspension) Batch No. – HIN039A / Qty.3113 vial |
10ml Vial | 415.24 | 408.10 | 0.00 | 408.10 |
| 7 | Monocomponent Insulin Huminsulin Regular 100 IU/ml (Insulin Human Injection ) Batch No. – FF6B71D / Qty.13300 Cartridges |
3ml Cartridge | 208.94 | 208.94 | 0.00 | 208.94 |
| 8 | Monocomponent Insulin Humalog Mix 50 100 IU/ml 50% Insulin Lispro and 50% Insulin Lispro protamine suspoension, r-DNA origin Batch No. – FF6B85D / Qty.5000 Cartridges |
3ml Cartridge | 440.43 | 445.74 | 0.00 | 445.74 |
| 9 | Monocomponent Insulin Humalog Mix 50 Pen 100 IU/ml 50% Insulin Lispro and 50% Insulin Lispro protamine suspoension, r-DNA origin Batch No. – FF5X28D / Qty.250 Disposable Pens |
3ml Disposable Pen | — | 588.75 | 0.00 | 588.75 |
| 10 | Monocomponent Insulin Humalog Pen 100 IU/ml (Insulin Lispro) Batch No. – FF5X27C / Qty.250 Disposable Pens |
3ml Disposable Pen | — | 588.75 | 0.00 | 588.75 |
| 11 | Monocomponent Insulin Humalog Mix 25 Pen 100 IU/ml 25% Insulin Lispro and 75% Insulin Lispro protamine suspoension, r-DNA origin Batch No. – FF5X74C / Qty.250 Disposable Pens |
3ml Disposable Pen | — | 588.75 | 0.00 | 588.75 |
2. This order shall be applicable if the manufacturer of the formulation specified in column (2) of the Table above has complied with the requirements, if any, of
(a) the Drugs and Cosmetics Act, 1940 (23 of 1940) and the rules made thereunder; and
(b) the Industries (Development and Regulation) Act, 1951 (65 of 1951) as amended from time to time.
3.(a) The prices fixed/revised is the Maximum Retail Prices (inclusive of excise duty and exclusive of local taxes, if any) for the specified pack and packs of similar strength. Companies cannot claim exemption on any ground therefrom, unless specifically permitted by the Government/NPPA through an order. For any increase/decrease in the Excise Duty by the Government of India, Ministry of Finance, the company is liable to adopt/implement the change accordingly Column (6) and Column (7) of the above table and issue supplementary price list thereon as per DPCO, 1995.
(b) For different packing material used or any special feature claimed, companies are required to approach NPPA for approval/fixation of specific prices.
4. These prices/revised prices shall be made effective within 15 days of receipt of this order as required under sub para 14(1) of DPCO, 1995. The necessary price-list should also be issued as required under sub-paragraph (3) of paragraph 14 of the Drugs (Prices Control) Order, 1995.
(A. K. PAL)
Dy. Director
PN/86/2006/F
M/s. Eli-Lilly and company (India) Pvt. Ltd.
Plot No. 92, Sector 32,
Gurgaon – 122 001.
Last Page Updated: 08-06-2019
Copyright © 2023 - All Rights Reserved- Official Website of National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Government of India
Note :Website Content Managed by National Pharmaceutical Pricing Authority Ministry of Chemicals and Fertilizers, Designed, Developed and Hosted by National Informatics Centre Services Inc.(NICSI)